- Home
- BRNS vs MKTW Comparison
BRNS vs MKTW Comparison
Compare BRNS & MKTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRNS
- MKTW
- Stock Information
- Founded
- BRNS 2016
- MKTW 1999
- Country
- BRNS United Kingdom
- MKTW United States
- Employees
- BRNS N/A
- MKTW N/A
- Industry
- BRNS Biotechnology: Pharmaceutical Preparations
- MKTW Computer Software: Prepackaged Software
- Sector
- BRNS Health Care
- MKTW Technology
- Exchange
- BRNS Nasdaq
- MKTW Nasdaq
- Market Cap
- BRNS 55.9M
- MKTW 46.9M
- IPO Year
- BRNS 2021
- MKTW N/A
- Fundamental
- Price
- BRNS $1.32
- MKTW $14.83
- Analyst Decision
- BRNS Strong Buy
- MKTW Hold
- Analyst Count
- BRNS 1
- MKTW 1
- Target Price
- BRNS $3.00
- MKTW $20.00
- AVG Volume (30 Days)
- BRNS 253.1K
- MKTW 11.8K
- Earning Date
- BRNS 11-06-2025
- MKTW 11-14-2025
- Dividend Yield
- BRNS N/A
- MKTW 5.41%
- EPS Growth
- BRNS N/A
- MKTW 59.71
- EPS
- BRNS N/A
- MKTW 2.83
- Revenue
- BRNS $14,969,000.00
- MKTW $358,121,000.00
- Revenue This Year
- BRNS N/A
- MKTW N/A
- Revenue Next Year
- BRNS N/A
- MKTW N/A
- P/E Ratio
- BRNS N/A
- MKTW $5.22
- Revenue Growth
- BRNS 1766.46
- MKTW N/A
- 52 Week Low
- BRNS $0.64
- MKTW $9.08
- 52 Week High
- BRNS $2.92
- MKTW $21.74
- Technical
- Relative Strength Index (RSI)
- BRNS 50.56
- MKTW 40.83
- Support Level
- BRNS $1.23
- MKTW $14.50
- Resistance Level
- BRNS $1.50
- MKTW $15.02
- Average True Range (ATR)
- BRNS 0.13
- MKTW 0.52
- MACD
- BRNS -0.02
- MKTW 0.12
- Stochastic Oscillator
- BRNS 22.22
- MKTW 61.29
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.
About MKTW MarketWise Inc.
Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.